Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVCGSBF 84 Return-on-Tangible-Asset is 8.19% as of Dec. 2024, which is 24% above its 10-year median of 6.63. GuruFocus rates CGSBF with a GF Scoreâ„¢ of 84/100 and a GF Valueâ„¢ of $44.58. Among 679 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks better than 76.88% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Corporativo FraguaB de CV's annualizedNet Income for the quarter that ended in Dec. 2024 was $235 Mil. Corporativo FraguaB de CV's average total tangible assets for the quarter that ended in Dec. 2024 was $2,870 Mil. Therefore, Corporativo FraguaB de CV's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was 8.19%.
The historical rank and industry rank for Corporativo FraguaB de CV's Return-on-Tangible-Asset or its related term are showing as below:
CGSBF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.12 Med: 6.63 Max: 9.56
Current: 9.07
During the past 13 years, Corporativo FraguaB de CV's highest Return-on-Tangible-Asset was 9.56%. The lowest was 6.12%. And the median was 6.63%.
CGSBF's Return-on-Tangible-Asset is ranked better than 76.88% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs CGSBF: 9.07
Corporativo FraguaB de CV (OTCPK:CGSBF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companyÂ’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companyÂ’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Corporativo FraguaB de CV Return-on-Tangible-Asset Related Terms
Corporativo FraguaB de CV Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Corporativo FraguaB de CV's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV Return-on-Tangible-Asset Chart
Corporativo FraguaB de CV Return-on-Tangible-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Dec. 2024) net income data.
What does a Return-on-Tangible-Asset of 8.19% mean?
Corporativo FraguaB de CV (CGSBF) has a Return-on-Tangible-Asset of 8.19% as of Dec. 2024. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Corporativo FraguaB de CV and its competitors. This is 24% above median its historical median of 6.63. Over the past decade, Corporativo FraguaB de CV's Return-on-Tangible-Asset has ranged from 6.12 to 9.56. According to the industry distribution chart, Corporativo FraguaB de CV ranks #157 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 23.1%.
Is Corporativo FraguaB de CV's Return-on-Tangible-Asset too high?
Corporativo FraguaB de CV's current Return-on-Tangible-Asset of 8.19% is 24% above median its 10-year median of 6.63. Over the past 10 years, this metric has ranged from a low of 6.12 to a high of 9.56. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. Corporativo FraguaB de CV's value of 8.19% is 226.3% above this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #157 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Corporativo FraguaB de CV has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #157 out of 679 companies for Return-on-Tangible-Asset. This places Corporativo FraguaB de CV in the top 23% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.51. Corporativo FraguaB de CV's value of 8.19% is 226.3% above this benchmark. Historically, Corporativo FraguaB de CV's own Return-on-Tangible-Asset has ranged from 6.12 to 9.56 over the past decade. While the company's 10-year median is 6.63 vs. the industry median of 2.51, Corporativo FraguaB de CV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current Return-on-Tangible-Asset of 8.19% is 226.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current Return-on-Tangible-Asset is 8.19%, which is 24% above median its own 10-year median of 6.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current Return-on-Tangible-Asset of 8.19%. The stock's GF Value™ is $44.58, compared to a current price of $29.66 — trading 33.5% below its estimated fair value. The current Return-on-Tangible-Asset is 8.19%, which is 24% above median its 10-year median of 6.63 and 226.3% above the Healthcare Providers & Services industry median of 2.51. Corporativo FraguaB de CV's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current Return-on-Tangible-Asset is 8.19% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (CGSBF) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of $29.66 is trading 33.5% below its estimated GF Value™ of $44.58.
Key valuation signals for CGSBF:
Return-on-Tangible-Asset: 8.19% (24% above median its 10-year median of 6.63)
GF Value™: $44.58 vs. price of $29.66 (33.5% below fair value)
Industry Position: 226.3% above the Healthcare Providers & Services median (#157 of 679)
No single metric tells the full story. See the CGSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
84GF Score
Get the complete analysis for CGSBF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
